Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Federal Trade Commission
Daiichi Sankyo
Queensland Health

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 016042

« Back to Dashboard

NDA 016042 describes DYAZIDE, which is a drug marketed by Glaxosmithkline Llc and is included in one NDA. It is available from two suppliers. Additional details are available on the DYAZIDE profile page.

The generic ingredient in DYAZIDE is hydrochlorothiazide; triamterene. There are thirty-two drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; triamterene profile page.
Summary for 016042
Applicant:Glaxosmithkline Llc
Ingredient:hydrochlorothiazide; triamterene
Formulation / Manufacturing:see details
Pharmacology for NDA: 016042
Suppliers and Packaging for NDA: 016042
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DYAZIDE hydrochlorothiazide; triamterene CAPSULE;ORAL 016042 NDA GlaxoSmithKline LLC 0007-3650 N 0007-3650-30
DYAZIDE hydrochlorothiazide; triamterene CAPSULE;ORAL 016042 NDA GlaxoSmithKline LLC 0007-3650 N 0007-3650-22

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength25MG;50MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength25MG;37.5MG
Approval Date:Mar 3, 1994TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.